These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
369 related articles for article (PubMed ID: 8658076)
21. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients. Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689 [TBL] [Abstract][Full Text] [Related]
22. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review. White A; Goetz MB Clin Infect Dis; 1994 Oct; 19(4):687-92. PubMed ID: 7803633 [TBL] [Abstract][Full Text] [Related]
23. [Fluconazole sensitivity of Candida strains in vitro in the microdilution test and agar diffusion test]. Metzger S; Jäger H; Hofmann H Mycoses; 1994; 37 Suppl 1():64-70. PubMed ID: 7854369 [TBL] [Abstract][Full Text] [Related]
24. A longitudinal study of the change in resistance patterns and genetic relationship of oral Candida albicans from HIV-infected patients. McCullough M; Hume S J Med Vet Mycol; 1995; 33(1):33-7. PubMed ID: 7650576 [TBL] [Abstract][Full Text] [Related]
25. Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease. Anil S; Ellepola AN; Samaranayake LP J Oral Pathol Med; 2001 Sep; 30(8):481-8. PubMed ID: 11545239 [TBL] [Abstract][Full Text] [Related]
26. Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors. Lacassin F; Damond F; Chochillon C; Longuet P; Lebras J; Vilde JL; Leport C Antimicrob Agents Chemother; 1996 Aug; 40(8):1961-3. PubMed ID: 8843316 [TBL] [Abstract][Full Text] [Related]
27. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. Ruhnke M; Eigler A; Tennagen I; Geiseler B; Engelmann E; Trautmann M J Clin Microbiol; 1994 Sep; 32(9):2092-8. PubMed ID: 7814530 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients. Menon T; Umamaheswari K; Kumarasamy N; Solomon S; Thyagarajan SP Acta Trop; 2001 Oct; 80(2):151-4. PubMed ID: 11600094 [TBL] [Abstract][Full Text] [Related]
29. [Correlation between resistance testing and typing of Candida albicans--isolates from AIDS patients and chronic recurrent oral candidiasis]. Ruhnke M; Tennagen I; Engelmann E Mycoses; 1994; 37 Suppl 1():60-3. PubMed ID: 7854368 [TBL] [Abstract][Full Text] [Related]
30. Activity of fluconazole against Candida albicans isolates from HIV+ patients in a digestive candidosis turkey model. Reynes J; Mallie M; Ravisse P; Bastide JM J Med Vet Mycol; 1992; 30(5):363-7. PubMed ID: 1469537 [TBL] [Abstract][Full Text] [Related]
31. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida]. Zhao M; Zhou ZT Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):218-20. PubMed ID: 16685371 [TBL] [Abstract][Full Text] [Related]
32. Changes in susceptibility to posaconazole in clinical isolates of Candida albicans. Li X; Brown N; Chau AS; López-Ribot JL; Ruesga MT; Quindos G; Mendrick CA; Hare RS; Loebenberg D; DiDomenico B; McNicholas PM J Antimicrob Chemother; 2004 Jan; 53(1):74-80. PubMed ID: 14657086 [TBL] [Abstract][Full Text] [Related]
33. [Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS]. Tebbe B; Boyvat A; Geilen CC; Wölfer LU; Seibold M; Orfanos CE Hautarzt; 1996 Feb; 47(2):136-9. PubMed ID: 8868459 [TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility and sterol biosynthesis of Candida albicans strains after long-term treatment with azoles in HIV-infected patients. Hundt W; Hofmann H Infection; 1994; 22(2):124-31. PubMed ID: 8070926 [TBL] [Abstract][Full Text] [Related]
35. Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient. Thomas-Greber E; Korting HC; Bogner J; Goebel FD Mycoses; 1994; 37(1-2):35-8. PubMed ID: 7935590 [TBL] [Abstract][Full Text] [Related]
36. Comparative evaluation of three antifungal susceptibility test methods for Candida albicans isolates and correlation with response to fluconazole therapy. Ruhnke M; Schmidt-Westhausen A; Engelmann E; Trautmann M J Clin Microbiol; 1996 Dec; 34(12):3208-11. PubMed ID: 8940474 [TBL] [Abstract][Full Text] [Related]
37. Stable azole drug resistance associated with a substrain of Candida albicans from an HIV-infected patient. White TC; Pfaller MA; Rinaldi MG; Smith J; Redding SW Oral Dis; 1997 May; 3 Suppl 1():S102-9. PubMed ID: 9456667 [TBL] [Abstract][Full Text] [Related]
38. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection. Redding SW; Pfaller MA; Messer SA; Smith JA; Prows J; Bradley LL; Fothergill AW; Rinaldi MG J Clin Microbiol; 1997 Jul; 35(7):1761-5. PubMed ID: 9196188 [TBL] [Abstract][Full Text] [Related]
39. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients. Troillet N; Durussel C; Bille J; Glauser MP; Chave JP Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):911-5. PubMed ID: 8187785 [TBL] [Abstract][Full Text] [Related]
40. Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissemination of fluconazole-resistant isolates. Dromer F; Improvisi L; Dupont B; Eliaszewicz M; Pialoux G; Fournier S; Feuillie V AIDS; 1997 Jul; 11(9):1095-101. PubMed ID: 9233455 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]